| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 3.4 | $0-$5k | 0.00 |
Summary
A vulnerability marked as problematic has been reported in IBM Algo One up to 4.7.1. This affects an unknown function. Performing a manipulation results in cross site scripting. This vulnerability is known as CVE-2013-6301. Remote exploitation of the attack is possible. No exploit is available.
Details
A vulnerability was found in IBM Algo One up to 4.7.1. It has been classified as problematic. This affects an unknown code. The manipulation with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity. The summary by CVE is:
Cross-site scripting (XSS) vulnerability in IBM Algo One, as used in MetaData Management Tools in UDS 4.7.0 through 5.0.0, ACSWeb in Algo Security Access Control Management 4.7.0 through 4.9.0, and ACSWeb in AlgoWebApps 5.0.0, allows remote authenticated users to inject arbitrary web script or HTML via unspecified vectors, a different vulnerability than CVE-2013-6299, CVE-2013-6300, CVE-2013-6320, and CVE-2013-6333.
The weakness was published 03/05/2014 (Website). The advisory is shared at xforce.iss.net. This vulnerability is uniquely identified as CVE-2013-6301 since 10/31/2013. It is possible to initiate the attack remotely. A authentication is needed for exploitation. It demands that the victim is doing some kind of user interaction. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1059.007 for this issue.
It is declared as highly functional.
The vulnerability is also documented in the databases at X-Force (88527), SecurityFocus (BID 65948†) and Secunia (SA57139†). Similar entries are available at VDB-66532, VDB-66531, VDB-66530 and VDB-66529. If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 3.5VulDB Meta Temp Score: 3.4
VulDB Base Score: 3.5
VulDB Temp Score: 3.4
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Highly functional
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
10/31/2013 🔍02/28/2014 🔍
03/05/2014 🔍
03/05/2014 🔍
03/24/2015 🔍
02/19/2018 🔍
Sources
Vendor: ibm.comAdvisory: xforce.iss.net
Status: Confirmed
Confirmation: 🔍
CVE: CVE-2013-6301 (🔍)
GCVE (CVE): GCVE-0-2013-6301
GCVE (VulDB): GCVE-100-66525
X-Force: 88527 - IBM Algo One cross-site scripting
SecurityFocus: 65948 - IBM Algo One CVE-2013-6301 Cross Site Scripting Vulnerability
Secunia: 57139
See also: 🔍
Entry
Created: 03/24/2015 15:54Updated: 02/19/2018 09:10
Changes: 03/24/2015 15:54 (54), 02/19/2018 09:10 (2)
Complete: 🔍
Cache ID: 216:A2A:103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.